All Updates

All Updates

icon
Filter
Funding
Kura Oncology announces USD 100 million underwritten public offering
Precision Medicine
Jun 14, 2023
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Jun 14, 2023

Kura Oncology announces USD 100 million underwritten public offering

Funding

  • Drug discovery and development company Kura Oncology announced an underwritten public offering of 5.7 million common shares and pre-funded warrants to purchase up to three million common shares. The company aims to raise approximately USD 100 million at a price of USD 11.50 per share.

  • Additionally, the company has granted underwriters a 30-day option to purchase an additional 1.3 million shares at the same price. The offering is expected to close on June 16, 2023, and the net proceeds will be utilized for various purposes, including drug candidate development and expanding clinical trials.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.